老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
JPMORGAN HEALTHCARE LEADERS ETF
61.55
+0.4699
0.77%
盤後：
61.08
-0.4699
-0.76%
16:10 EDT
成交量：
23
成交額：
1,470
市值：
923.22萬
市盈率：
- -
高：
61.55
開：
61.08
低：
61.55
收：
61.08
52周最高：
64.69
52周最低：
50.34
股本：
15.00萬
流通股本：
15.00萬
量比：
0.13
換手率：
0.02%
股息：
0.51
股息率：
0.83%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
禮來擬收購Merida Biosciences，深化嚴重自身免疫及過敏性疾病治療佈局
美股速递
·
08/31
歌禮制藥-B(01672)：每日一次口服小分子GLP-1受體激動劑ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
智通财经
·
08/30
歌禮制藥-B(01672.HK)：每日一次口服小分子GLP-1受體激動劑ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥
智通财经
·
08/30
印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？
华尔街见闻
·
08/29
BioNTech在進行安全性審查後終止了mRNA結直腸癌疫苗的臨床試驗
路透中文
·
08/28
美股生物醫藥股盤初走低，BioNTech跌超9%、Moderna跌近5%
老虎资讯综合
·
08/28
從降糖減重到心血管保護! Mounjaro完成「心代謝躍遷」，禮來打開GLP-1第二增長曲線
智通财经
·
08/28
從降糖減重到心血管保護! Mounjaro完成「心代謝躍遷」，禮來(LLY.US)打開GLP-1第二增長曲線
智通财经
·
08/28
美國食品藥品監督管理局（FDA）批准禮來公司的Mounjaro用於降低心血管風險
路透中文
·
08/28
FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險
美股速递
·
08/28
焦點-歷經一個世紀的失敗後終於取得成功：揭秘莫德納和默克癌症疫苗的突破
路透中文
·
08/28
焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變
路透中文
·
08/28
金佰利·克拉克尋求歐盟批准這筆400億美元的Kenvue收購交易
路透中文
·
08/28
伯維（ABBV）向EMA遞交Skyrizi克羅恩病治療上市申請
金吾财讯
·
08/27
中國批准強生公司口服銀屑病藥，該藥企表示
路透中文
·
08/27
強生口服Icotrokinra在華獲批，用於治療中重度斑塊狀銀屑病
美股速递
·
08/27
強生公司8月27日宣佈，白介素23（IL-23）受體拮抗劑艾特雅（鹽酸伊可白滯素片）已正式獲得中國國家藥品監督管理局批准
智通财经
·
08/27
強生靶向口服肽類藥物艾特雅在華獲批
智通财经
·
08/27
兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理
智通财经
·
08/27
艾伯維向歐洲藥品管理局提交Skyrizi®（瑞莎珠單抗）皮下誘導治療申請，針對中重度活動性克羅恩病成人患者
美股速递
·
08/27
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/JDOC/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"JDOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","market":"US","secType":"STK","nameCN":"JPMORGAN HEALTHCARE LEADERS ETF","latestPrice":61.5483,"timestamp":1789675200000,"preClose":61.0784,"halted":0,"volume":23,"hourTrading":{"tag":"盘后","latestPrice":61.0784,"preClose":61.5483,"latestTime":"16:10 EDT","volume":6,"amount":369.2898,"timestamp":1789675804203,"change":-0.4699,"changeRate":-0.007635,"amplitude":0},"delay":0,"changeRate":0.007693390789542547,"floatShares":150000,"shares":150000,"eps":0,"marketStatus":"未開盤","change":0.4699,"latestTime":"09-17 16:00:00 EDT","open":61.0784,"high":61.5483,"low":61.5483,"amount":1470,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":61.0784,"sharesOutstanding":150000,"nav":61.05,"aum":9157521.55,"dividendRate":0.008299,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":61.0784,"preClose":61.5483,"latestTime":"16:10 EDT","volume":6,"amount":369.2898,"timestamp":1789675804203,"change":-0.4699,"changeRate":-0.007635,"amplitude":0},"volumeRatio":0.125683},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","floatShares":150000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.125683,"shares":150000,"dividePrice":0.5108,"high":61.5483,"amplitude":0,"preClose":61.0784,"low":61.5483,"week52Low":50.34,"pbRate":"--","week52High":64.69,"institutionHeld":0,"latestPrice":61.5483,"eps":0,"divideRate":0.008299,"volume":23,"delay":0,"ttmEps":0,"open":61.0784,"prevYearClose":57.9058,"prevWeekClose":60.7158,"prevMonthClose":62.5974,"prevQuarterClose":60.2303,"fiveDayClose":60.8066,"twentyDayClose":64.5591,"sixtyDayClose":56.2419},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JDOC\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"JDOC","amount":0.5121,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-18","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-18"},{"date":"2024-12-24","symbol":"JDOC","amount":0.3276,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-27"},{"date":"2024-12-16","symbol":"JDOC","amount":2.48902,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-18"},{"date":"2023-12-19","symbol":"JDOC","amount":0.07965,"announcedDate":"2023-12-18","type":"dividend","market":"US","newRecordDate":"2023-12-20","defaultRemindTime":1702996200000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","recordDate":"2023-12-22","payableDate":"2023-12-20","currency":"USD","dateTimestamp":1702962000000,"payDate":"2023-12-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JDOC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-19","recordDate":"2023-12-20","paymentDate":"2023-12-22","value":0.07965,"currency":"USD"},{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-18","value":2.48902,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-27","value":0.3276,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-18","value":0.5121,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JDOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JDOC\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171558090","title":"禮來擬收購Merida Biosciences，深化嚴重自身免疫及過敏性疾病治療佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1171558090","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171558090?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:46","pubTimestamp":1788173192,"startTime":"0","endTime":"0","summary":"礼来公司宣布，将收购Merida Biosciences，此举旨在进一步推进针对严重自身免疫性疾病和过敏性疾病的治疗方案研发。这一战略动作，标志着礼来在生物制药领域，尤其是在未被满足的医疗需求方面，正加速其布局与投入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2211815571.USD","LU2746668461.USD","LU2750360997.AUD","LU0289739699.SGD","IE00BWXC8680.SGD","LU0689472784.USD","LU0823416689.USD","SG9999015952.SGD","SGXZ81514606.USD","LU0354030511.USD","LU2357305700.SGD","LU0820562030.AUD","LU2471134796.USD","IE0001KFT4U8.USD","ELIL","LU0058720904.USD","LU2168563687.JPY","LU0266013472.USD","LU0456855351.SGD","IE00B7KXQ091.USD","LU0133085943.USD","LU2213496289.HKD","LU2456880835.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU2237438978.USD","LU0882574055.USD","LU2237443549.SGD","LU0787776722.HKD","LU0823434740.USD","LU1917777945.USD","MEDX","LU1280957306.USD","VHT","LU1979441026.SGD","PPH","IXJ","LU0882574139.USD","IE00BKDWB100.SGD","LU1267930730.SGD","LU1145028129.USD","LU2552382132.HKD","LU0320765992.SGD","IE00BN29S564.USD","LU0079474960.USD","LU2462157665.USD","LU2265009873.SGD","SGXZ57979304.SGD","LU1868836591.USD","LU1804176565.USD","LU2237443978.SGD","JDOC","LU2896262040.SGD","LU2417539215.USD","IE00BFSS7M15.SGD","THNR","LU0109391861.USD","SG9999014880.SGD","SGXZ51526630.SGD","LU1712237335.SGD","LU2111349929.HKD","TMED","LU1069344957.HKD","RXL","LU0943347566.SGD","LU0122379950.USD","LU0316494557.USD","IE00B1XK9C88.USD","LU1623119135.USD","LU2361045086.USD","LU1551013425.SGD","LU0256863811.USD","SG9999001176.SGD","SG9999015978.USD","LU2756315664.SGD","LU1023059063.AUD","LU1057294990.SGD","SGXZ31699556.SGD","LU1814569148.SGD","BK4516","LLY","LU1093756325.SGD","LU1974910355.USD","PJP","IE0005OL40V9.USD","IE0009355771.USD","LU0471298777.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU0353189680.USD","LU1291159041.SGD","LU0823434583.USD","LU1868836757.USD","LU1720051108.HKD","LU2023250330.USD","LU2168564495.EUR","SGXZ99366536.SGD","IE00BJT1NW94.SGD","MHIP","LU0889565916.HKD","LU2108987350.USD","LU2468319806.SGD","LU0345770993.USD","LU0097036916.USD","LU2106854487.HKD","LU0114720955.EUR","LU2237443622.USD","LU2237443895.HKD","LU2361044865.SGD","LU2552382058.USD","IE00B4JS1V06.HKD","FTXH","LU1868837136.USD","BK4534","LU0158827781.USD","LU0094547139.USD","BK4533","LU1323610961.USD","BK4581","SG9999014898.SGD","LU2089284900.SGD","WDNA","LU2471134952.CNY","LU0672654240.SGD","LU2112291526.USD","LU2237443382.USD","LU0964807845.USD","XLV","SG9999001176.USD","LLYZ","LLII","IE00BJLML261.HKD","IE00BJJMRY28.SGD","LU2361044949.HKD","LU0417517546.SGD","LU0385154629.USD","TRUH","LU2168564222.USD","IYH","LU0345770308.USD","LU0096364046.USD","LU1691799644.USD","LU0471298694.HKD","IE0004445239.USD","LLYX","LU0466842654.USD","LU2264538146.SGD","LU1868837300.USD","LU0354030438.USD","LU2271345857.HKD","LU2087625088.SGD","LU0174119429.USD","LU2471134523.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0708995401.HKD","HRTS","SG9999018865.SGD","OZEM","LU2023251221.USD","LU0640476718.USD","LU0683600562.USD","LU1629891620.HKD","LU0353189763.USD","LU1983299246.USD","SG9999017495.SGD","SG9999014906.USD","IE00B775H168.HKD","LU1093756168.USD","IHE","IE00BJJMRX11.SGD","LU2324357040.USD","LU1868836914.USD","LU1989771016.USD","LU0225283273.USD","LU2471134879.HKD","LU2756315318.SGD","LU2462591350.SGD","LU1548497426.USD","ELIS","IE0004445015.USD","LU0061475181.USD","LU1035775433.USD","LU2491050154.USD","LU2746668974.SGD","SG9999018857.SGD","CANC","FHLC","IE00BK4W5M84.HKD","LU2089283258.USD","LU0320765059.SGD","SG9999014914.USD","BK4588","LU0234572021.USD","BK4599","LU0432979614.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU0820561909.HKD","LU0323591593.USD","LU1232071149.USD","LU2461242641.AUD","LU0109394709.USD","LU2063271972.USD","IE00BKPKM429.USD","IE00B2B36J28.USD","LU0203201768.USD","LU1988902786.USD","LU2602419157.SGD","LU0106261372.USD","LU2237443465.HKD","LU2552382215.SGD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0006306889.USD","CURE","IE00BJJMRZ35.SGD","LU2750360641.GBP","LU1061106388.HKD","AGNG","LU2360106947.USD","SG9999013999.USD","LU1127390331.HKD","LU0198837287.USD","LU0238689110.USD","LU1366192091.USD","LU2028103732.USD","LU2168564149.EUR","LU0820561818.USD","BK4585","LU0210536198.USD","LU0786609619.USD","GDOC","BK4007","IE0002141913.USD","MEDI","ILDR","LU2023250504.SGD","LU2491050071.SGD","LU1720051017.SGD","LU2236285917.USD","GB00BDT5M118.USD","LU2089984988.USD","LU0158827948.USD","LU2168564065.EUR","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663415150","title":"歌禮制藥-B(01672)：每日一次口服小分子GLP-1受體激動劑ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2663415150","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663415150?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 18:08","pubTimestamp":1788084524,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，ASC30用于长期体重管理的全球III期临床项目已完成首例受试者给药。ASC30是一款歌礼专有的、正在临床研究中的每日一次口服小分子胰高血糖素样肽-1受体激动剂，开发用于长期体重管理和糖尿病治疗。歌礼预计将于2028年第三季度公布AURORA III期临床项目的顶线数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK1161","01672","BK1191","JDOC","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041516","title":"歌禮制藥-B(01672.HK)：每日一次口服小分子GLP-1受體激動劑ASC30用於長期體重管理的全球III期臨床項目完成首例受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041516","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041516?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 18:08","pubTimestamp":1788084524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663168590","title":"印度糖尿病全球第二多，月費降至14美元，GLP-1減肥藥為何仍賣不動？","url":"https://stock-news.laohu8.com/highlight/detail?id=2663168590","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663168590?lang=zh_tw&edition=fundamental","pubTime":"2026-08-29 05:55","pubTimestamp":1787954138,"startTime":"0","endTime":"0","summary":"印度减肥药市场正在给全球制药行业上一堂关于市场预期的警示课。尽管GLP-1类药物在印度已实现大规模仿制、价格降至每月14美元，销售表现却远逊于预期，揭示出价格之外更深层的文化、社会与监管障碍。截至今年7月，约三十余种仿制GLP-1药物已在印度药房上市。市场冷淡直接冲击了制药行业对印度的增长押注。印度市场本被视为GLP-1药物向美欧以外拓展的重要试验场。","market":"nz","thumbnail":"https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/62df7fa563e423b513600a842a6669e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3780608","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","MEDI","ELIL","FXH","LLII","JDOC","PJP","OZEM","NVOH","ELIS","THNR","NVOC","NBDS","UUP","UDN","PINK","CURE","IYH","LLYX","XLVI","RSPH","TRUH","MNDmain","NVOX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662096800","title":"BioNTech在進行安全性審查後終止了mRNA結直腸癌疫苗的臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096800","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662096800?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 21:40","pubTimestamp":1787924401,"startTime":"0","endTime":"0","summary":"BioNTech此次临床试验失败，正值默克公司MRK.N和莫德纳公司MRNA.O宣布其基于mRNA的疫苗 在一项 涉及1,000多名患者的试验中，成功帮助预防了黑色素瘤复发和扩散的数日之后。负责监督BioNTech试验安全性和完整性的委员会发现，研究中各患者组在总生存期方面存在“数值不平衡”。BioNTech未对置评请求作出回应。BioNTech 还在开发其他基于 mRNA 的癌症疗法，包括用于头颈部癌症的 BNT113。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4S44P140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","GDOC","IXJ","GNOM","BK4550","LU1116320901.HKD","LU1699723380.USD","IHE","IE00BBT3K403.USD","RXL","LU1989772840.SGD","SG9999014575.USD","LU0130102774.USD","LU0320765646.SGD","MRNY","XLV","IE00B2B36J28.USD","FTXH","LU0942090050.USD","SG9999015341.SGD","IE00BSNM7G36.USD","HRTS","SGXZ57979304.SGD","TRUH","JDOC","LU0070302665.USD","SG9999015358.SGD","BMED","IE00B1BXHZ80.USD","MRK","IE0002141913.USD","BNTX","LU0265550359.USD","FHLC","LU0868494708.USD","PPH","LU0648001328.SGD","MRNX","LU2112291526.USD","IE00BLSP4239.USD","LU0238689110.USD","IYH","LU1116320737.USD","LGHT","VHT","LU2491049909.HKD","MRNA","PAWZ","LU0985320562.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100460280","title":"美股生物醫藥股盤初走低，BioNTech跌超9%、Moderna跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100460280","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100460280?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 21:37","pubTimestamp":1787924271,"startTime":"0","endTime":"0","summary":"8月28日，美股生物医药股盘初走低，$BioNTech(BNTX)$跌超9%，公司宣布终止结直肠癌2期临床试验；$Moderna(MRNA)$跌近5%，$默沙东(MRK)$跌1.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","GNOM","BK4007","LU2360032135.SGD","LU0006306889.USD","LU1023059063.AUD","LU1585245621.USD","BK4551","LU1989772840.SGD","LU0130102774.USD","MRNY","LU2125909593.SGD","LU1934455277.USD","FTXH","SG9999015341.SGD","BK4568","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0203345920.USD","JDOC","LU0965509010.AUD","LU1057294990.SGD","LU1066051811.HKD","LU1929549753.HKD","LU2491050154.USD","LU1917777945.USD","BK4559","LU2112291526.USD","LU0122379950.USD","LU0689626769.HKD","LU1162221912.USD","LU1941712348.USD","LU0868494617.USD","LU2106854487.HKD","LU0477156953.USD","LU1923622614.USD","LU1061106388.HKD","LU0320765489.SGD","WDNA","LU1430594728.SGD","LU1983299246.USD","BK4550","LU2324357040.USD","SG9999002224.SGD","LU1699723380.USD","IHE","IE00BBT3K403.USD","RXL","MDTX","LU0265550946.USD","LU0320765646.SGD","LU0124676726.USD","XLV","IE0009355771.USD","LU1291159041.SGD","LU1066051225.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","SG9999015358.SGD","LU2023250843.SGD","LU1093756168.USD","LU0861579265.USD","SG9999001176.SGD","BNTX","LU2125909247.SGD","LU0868494708.USD","LU2461242641.AUD","LU2125154935.USD","BK4548","LU0106261372.USD","LU1037948897.HKD","LU1989771016.USD","LU2491049909.HKD","BK4588","LU0130517989.USD","LU2361044949.HKD","PAWZ","LU1934455863.HKD","XBI","LU0203347892.USD","LU0289739699.SGD","LU1035773651.USD","BK4501","LU0208291251.USD","LU0823416689.USD","LU1037948541.HKD","LU1066053197.SGD","IE00B2B36J28.USD","LU0942090050.USD","LU1201861249.SGD","161726","LU1069347547.HKD","TRUH","LU2433249047.HKD","BK4532","BK4534","LU0859254822.USD","BK4585","BMED","MRK","IE00BN8TJ469.HKD","LU1974910355.USD","IE00BJT1NW94.SGD","LU2357627491.SGD","PPH","IE000M9KFDE8.USD","LU0965508806.USD","LU1571399168.USD","MRNX","LU0238689110.USD","SG9999001176.USD","IYH","SG9999014559.SGD","LU2361044865.SGD","PSYK","IE00BFTCPJ56.SGD","LU1989772923.USD","SG9999014567.USD","LU0985320562.USD","LU0266013472.USD","IDNA","LU0058720904.USD","IBBJ","SG9999001440.SGD","GDOC","LU0098860793.USD","IXJ","SG9999014542.SGD","LU2089984988.USD","LU1116320901.HKD","SG9999014575.USD","IE00BLSP4452.SGD","BK4139","LU2361045086.USD","LU0980610538.SGD","BK4516","LU0965509101.SGD","IBBQ","HRTS","SGXZ57979304.SGD","BK4533","SG9999013999.USD","LU1066051498.USD","IE00B1BXHZ80.USD","IE0002141913.USD","LU0265550359.USD","FHLC","LU0965509283.SGD","LU0648001328.SGD","LU2125154778.USD","LU0211331839.USD","LU0432979614.USD","SG9999002232.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1941712264.USD","LU1934455194.USD","BK4581","LU1116320737.USD","LGHT","LU2491050071.SGD","MRNA","VHT","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662981930","title":"從降糖減重到心血管保護! Mounjaro完成「心代謝躍遷」，禮來打開GLP-1第二增長曲線","url":"https://stock-news.laohu8.com/highlight/detail?id=2662981930","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662981930?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:35","pubTimestamp":1787920555,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局此次批准Mounjaro用于降低伴有心脏病的2型糖尿病成人发生心血管死亡、非致死性心肌梗死或非致死性卒中的风险，进一步增强其相对于最大规模竞争对手诺和诺德旗下减肥与降糖药Ozempic的竞争优势。诺和诺德公司的竞争性糖尿病注射药物Ozempic已经获得心血管疾病适应症批准。服用Mounjaro的患者全因死亡人数减少了16%。此次获批的是Mounjaro心血管适应症，并不等于Zepbound已经获批用于心血管一级或二级预防。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488344.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662981180","title":"從降糖減重到心血管保護! Mounjaro完成「心代謝躍遷」，禮來(LLY.US)打開GLP-1第二增長曲線","url":"https://stock-news.laohu8.com/highlight/detail?id=2662981180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662981180?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:22","pubTimestamp":1787919775,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662608062","title":"美國食品藥品監督管理局（FDA）批准禮來公司的Mounjaro用於降低心血管風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2662608062","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662608062?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:05","pubTimestamp":1787915151,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准礼来公司的Mounjaro用于降低心血管风险路透8月28日-礼来公司（LLY.N）周五表示，美国食品药品监督管理局（FDA）已批准其糖尿病药物Mounjaro，用于降低患有2型糖尿病且发生重大心血管不良事件风险较高的成年患者的该类事件风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU2211815571.USD","LU2746668461.USD","LU2750360997.AUD","LU0289739699.SGD","IE00BWXC8680.SGD","LU0689472784.USD","LU0823416689.USD","SG9999015952.SGD","SGXZ81514606.USD","LU0354030511.USD","LU2357305700.SGD","LU0820562030.AUD","LU2471134796.USD","IE0001KFT4U8.USD","ELIL","LU0058720904.USD","LU2168563687.JPY","LU0266013472.USD","LU0456855351.SGD","IE00B7KXQ091.USD","LU0133085943.USD","LU2213496289.HKD","LU2456880835.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","LU2237438978.USD","LU0882574055.USD","LU2237443549.SGD","LU0787776722.HKD","LU0823434740.USD","LU1917777945.USD","MEDX","LU1280957306.USD","VHT","LU1979441026.SGD","PPH","IXJ","LU0882574139.USD","IE00BKDWB100.SGD","LU1267930730.SGD","LU1145028129.USD","LU2552382132.HKD","LU0320765992.SGD","IE00BN29S564.USD","LU0079474960.USD","LU2462157665.USD","LU2265009873.SGD","SGXZ57979304.SGD","LU1868836591.USD","LU1804176565.USD","LU2237443978.SGD","JDOC","LU2896262040.SGD","LU2417539215.USD","IE00BFSS7M15.SGD","THNR","LU0109391861.USD","SG9999014880.SGD","SGXZ51526630.SGD","LU1712237335.SGD","LU2111349929.HKD","TMED","LU1069344957.HKD","RXL","LU0943347566.SGD","LU0122379950.USD","LU0316494557.USD","IE00B1XK9C88.USD","LU1623119135.USD","LU2361045086.USD","LU1551013425.SGD","LU0256863811.USD","SG9999001176.SGD","SG9999015978.USD","LU2756315664.SGD","LU1023059063.AUD","LU1057294990.SGD","SGXZ31699556.SGD","LU1814569148.SGD","BK4516","LLY","LU1093756325.SGD","LU1974910355.USD","PJP","IE0005OL40V9.USD","IE0009355771.USD","LU0471298777.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU0353189680.USD","LU1291159041.SGD","LU0823434583.USD","LU1868836757.USD","LU1720051108.HKD","LU2023250330.USD","LU2168564495.EUR","SGXZ99366536.SGD","IE00BJT1NW94.SGD","MHIP","LU0889565916.HKD","LU2108987350.USD","LU2468319806.SGD","LU0345770993.USD","LU0097036916.USD","LU2106854487.HKD","LU0114720955.EUR","LU2237443622.USD","LU2237443895.HKD","LU2361044865.SGD","LU2552382058.USD","IE00B4JS1V06.HKD","FTXH","LU1868837136.USD","BK4534","LU0158827781.USD","LU0094547139.USD","BK4533","LU1323610961.USD","BK4581","SG9999014898.SGD","LU2089284900.SGD","WDNA","LU2471134952.CNY","LU0672654240.SGD","LU2112291526.USD","LU2237443382.USD","LU0964807845.USD","XLV","SG9999001176.USD","LLYZ","LLII","IE00BJLML261.HKD","IE00BJJMRY28.SGD","LU2361044949.HKD","LU0417517546.SGD","LU0385154629.USD","TRUH","LU2168564222.USD","IYH","LU0345770308.USD","LU0096364046.USD","LU1691799644.USD","LU0471298694.HKD","IE0004445239.USD","LLYX","LU0466842654.USD","LU2264538146.SGD","LU1868837300.USD","LU0354030438.USD","LU2271345857.HKD","LU2087625088.SGD","LU0174119429.USD","LU2471134523.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0708995401.HKD","HRTS","SG9999018865.SGD","OZEM","LU2023251221.USD","LU0640476718.USD","LU0683600562.USD","LU1629891620.HKD","LU0353189763.USD","LU1983299246.USD","SG9999017495.SGD","SG9999014906.USD","IE00B775H168.HKD","LU1093756168.USD","IHE","IE00BJJMRX11.SGD","LU2324357040.USD","LU1868836914.USD","LU1989771016.USD","LU0225283273.USD","LU2471134879.HKD","LU2756315318.SGD","LU2462591350.SGD","LU1548497426.USD","ELIS","IE0004445015.USD","LU0061475181.USD","LU1035775433.USD","LU2491050154.USD","LU2746668974.SGD","SG9999018857.SGD","CANC","FHLC","IE00BK4W5M84.HKD","LU2089283258.USD","LU0320765059.SGD","SG9999014914.USD","BK4588","LU0234572021.USD","BK4599","LU0432979614.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU0820561909.HKD","LU0323591593.USD","LU1232071149.USD","LU2461242641.AUD","LU0109394709.USD","LU2063271972.USD","IE00BKPKM429.USD","IE00B2B36J28.USD","LU0203201768.USD","LU1988902786.USD","LU2602419157.SGD","LU0106261372.USD","LU2237443465.HKD","LU2552382215.SGD","IE00B1BXHZ80.USD","LU0256863902.USD","LU0006306889.USD","CURE","IE00BJJMRZ35.SGD","LU2750360641.GBP","LU1061106388.HKD","AGNG","LU2360106947.USD","SG9999013999.USD","LU1127390331.HKD","LU0198837287.USD","LU0238689110.USD","LU1366192091.USD","LU2028103732.USD","LU2168564149.EUR","LU0820561818.USD","BK4585","LU0210536198.USD","LU0786609619.USD","GDOC","BK4007","IE0002141913.USD","MEDI","ILDR","LU2023250504.SGD","LU2491050071.SGD","LU1720051017.SGD","LU2236285917.USD","GB00BDT5M118.USD","LU2089984988.USD","LU0158827948.USD","LU2168564065.EUR","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168986397","title":"FDA批准禮來Mounjaro（替爾泊肽）用於降低2型糖尿病成人患者心血管風險","url":"https://stock-news.laohu8.com/highlight/detail?id=1168986397","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168986397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 19:02","pubTimestamp":1787914941,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准礼来旗下药物 Mounjaro的新适应症——用于降低伴有2型糖尿病的成年患者心血管事件风险。这一决定为众多糖尿病合并心血管高风险人群带来了新的治疗选项。此次获批标志着替尔泊肽在代谢与心血管交叉领域的又一重要进展。随着适应症范围的扩大，替尔泊肽的临床使用覆盖面将更加广泛，有望进一步重塑2型糖尿病合并心血管疾病患者的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836591.USD","LU1623119135.USD","SGXZ51526630.SGD","IE0009355771.USD","LU0096364046.USD","LU1988902786.USD","BK4534","LU0787776722.HKD","CURE","LU0203202063.USD","LU2089284900.SGD","IE00B7KXQ091.USD","RXL","OZEM","FTXH","TMED","LU0471298694.HKD","IE00B2B36J28.USD","LU2417539215.USD","LLII","LU0708995401.HKD","IE0002141913.USD","LU0122379950.USD","LU0158827948.USD","LU2237443465.HKD","IHE","SG9999001176.USD","SG9999014914.USD","LU0079474960.USD","LU0889565916.HKD","IE00BFSS7M15.SGD","LU0882574055.USD","LU0943347566.SGD","LU2106854487.HKD","LU1868837136.USD","MEDI","LU1868836914.USD","LU2456880835.USD","GDOC","IE00BK4W5L77.USD","LU2087625088.SGD","LU2271345857.HKD","LU0198837287.USD","LU1323610961.USD","LU2471134879.HKD","LU1551013425.SGD","LU1868837300.USD","THNR","VHT","SG9999018865.SGD","XLV","IE00BFSS8Q28.SGD","LU2168564065.EUR","LU1720051108.HKD","ELIL","LU2264538146.SGD","SG9999015978.USD","LU0882574139.USD","IYH","LU0109394709.USD","LU1868836757.USD","LU2237443895.HKD","IE00BJJMRZ35.SGD","IE00B4JS1V06.HKD","IE00BN29S564.USD","LU2237443622.USD","IE00BJJMRX11.SGD","LU2023250330.USD","LU0823434740.USD","LU1974910355.USD","LU0964807845.USD","LU2168564222.USD","LU1917777945.USD","LU2237443549.SGD","LU2471134796.USD","LU2468319806.SGD","LU2552382215.SGD","LU0353189680.USD","MHIP","LU1691799644.USD","LU0689472784.USD","LU0471298777.SGD","SGXZ99366536.SGD","IE00B775H168.HKD","BK4533","LU0417517546.SGD","LU0823434583.USD","IE0004445015.USD","LU2089283258.USD","LU2361045086.USD","CANC","LU2236285917.USD","LU2552382132.HKD","JDOC","LU1093756325.SGD","LU1127390331.HKD","BK4581","SG9999014906.USD","LU0466842654.USD","LU2028103732.USD","LU2361044949.HKD","LU0432979614.USD","SG9999014880.SGD","LU0786609619.USD","LU0061475181.USD","LU0640476718.USD","LU1989771016.USD","LU2237438978.USD","LU2491050154.USD","BK4585","SG9999001176.SGD","LU1057294990.SGD","LU1093756168.USD","HRTS","BK4007","SG9999015945.SGD","LU2023251221.USD","LU0097036916.USD","LU1064131342.USD","SGXZ57979304.SGD","LU0203201768.USD","IE00BWXC8680.SGD","ELIS","IE00B4R5TH58.HKD","SG9999018857.SGD","LU1720051017.SGD","LU0225283273.USD","LU1145028129.USD","LU0266013472.USD","IE00BJLML261.HKD","LU0256863811.USD","LU0114720955.EUR","LU0353189763.USD","LU0820562030.AUD","SG9999013999.USD","LU2168563687.JPY","LU2756315664.SGD","LU2756315318.SGD","LU2063271972.USD","GB00BDT5M118.USD","IE00BJT1NW94.SGD","LU2750360997.AUD","SGXZ81514606.USD","LU2491050071.SGD","LU0210536198.USD","IE00B1XK9C88.USD","SG9999015986.USD","LU1629891620.HKD","LU2324357040.USD","LU0820561818.USD","LU0006306889.USD","LU2746668974.SGD","LU1023059063.AUD","LU0354030511.USD","LU0234572021.USD","LU1548497426.USD","LU2602419157.SGD","LU2112291526.USD","IE0001KFT4U8.USD","LU2237443382.USD","LU2357305700.SGD","LU0683600562.USD","LU2211815571.USD","LU2237443978.SGD","LU1267930730.SGD","LU2265009873.SGD","LU0058720904.USD","LU0238689110.USD","BK4516","IE00B1BXHZ80.USD","LU0320765059.SGD","LU0323591593.USD","LU1804176565.USD","SG9999014898.SGD","WDNA","LU2750360641.GBP","AGNG","LU2108987350.USD","LU0320765992.SGD","LU1280957306.USD","LU2089984988.USD","LU2471134952.CNY","LU2896262040.SGD","LU0456855351.SGD","LU0385154629.USD","LU0174119429.USD","SGXZ31699556.SGD","LU1814569148.SGD","LU0106261372.USD","ILDR","LU2213496289.HKD","LU2111349929.HKD","LU2746668461.USD","SG9999015952.SGD","IE00BFTCPJ56.SGD","LU2462591350.SGD","LU1712237335.SGD","LU2023250504.SGD","LLYX","LU2462157665.USD","LU0672654240.SGD","LU2461242641.AUD","LLY","MEDX","PPH","BK4599","TRUH","LU0345770308.USD","LU2360106947.USD","IE0004445239.USD","LU0345770993.USD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0316494557.USD","LU2552382058.USD","LU0109391861.USD","LU1061106388.HKD","LU1551013342.USD","BK4588","LU0820561909.HKD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","LU1979441026.SGD","SG9999017495.SGD","LU0256863902.USD","FHLC","LU1983299246.USD","LU1035775433.USD","LU1232071149.USD","IXJ","LU0289739699.SGD","LU2168564149.EUR","LU2168564495.EUR","LU2361044865.SGD","LU2491049909.HKD","IE00BKDWB100.SGD","LU0094547139.USD","IE0005OL40V9.USD","LLYZ","LU0354030438.USD","PJP","LU2471134523.USD","LU0133085943.USD","LU1069344957.HKD","LU0823416689.USD","LU1291159041.SGD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069588","title":"焦點-歷經一個世紀的失敗後終於取得成功：揭秘莫德納和默克癌症疫苗的突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069588","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069588?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911290,"startTime":"0","endTime":"0","summary":"焦点-历经一个世纪的失败后终于取得成功：揭秘莫德纳和默克癌症疫苗的突破Michael Erman/Julie Steenhuysen路透8月28日-8月13日晚，莫德纳公司MRNA.O首席执行官斯特凡·班塞尔正在一家黎巴嫩餐厅为朋友庆祝生日，这时他接到了电话。此前，一些试图训练免疫系统针对一两个特定肿瘤突变的癌症疫苗均以失败告终。美国可能最早于明年批准该疫苗。莫德纳股价此前较新冠疫情期间的高点已下跌约90%，但自疫苗试验结果公布以来已上涨逾130%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","WDNA","BK4007","LU1093756168.USD","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999001176.USD","IHE","LU0477156953.USD","SG9999002224.SGD","LU0265550946.USD","LU0266013472.USD","SG9999001440.SGD","IXJ","SG9999014575.USD","LU0980610538.SGD","LU1066053197.SGD","BK4548","LU2125909247.SGD","LU1585245621.USD","LU0238689110.USD","LU0823416689.USD","BK4559","IE00B2B36J28.USD","LU1116320737.USD","LU0203347892.USD","LU0211331839.USD","IE00BLSP4452.SGD","LU0985320562.USD","LU2125154935.USD","LGHT","LU2491050071.SGD","LU1066051811.HKD","LU0289739699.SGD","LU1066051498.USD","LU2433249047.HKD","LU1941712348.USD","BK4585","BMED","IE00BJJMRZ35.SGD","PAWZ","VHT","LU0689626769.HKD","IE00BLSP4239.USD","LU1430594728.SGD","IE0002141913.USD","LU1934455194.USD","BK4532","LU1201861249.SGD","IE000M9KFDE8.USD","MRNY","LU0203345920.USD","FHLC","MRNA","LU1699723380.USD","LU1035773651.USD","LU0070302665.USD","LU0124676726.USD","FTXH","LU1989771016.USD","LU0432979614.USD","BK4588","BK4568","LU1983299246.USD","SG9999015341.SGD","IDNA","BK4551","IYH","LU1989772840.SGD","LU2125909593.SGD","SG9999013999.USD","SGXZ57979304.SGD","LU0868494708.USD","LU0006306889.USD","IE00BN8TJ469.HKD","LU1037948897.HKD","LU1116320901.HKD","LU2023250843.SGD","RXL","MRK","LU0942090050.USD","LU2361044949.HKD","LU1061106388.HKD","BK4501","LU2361045086.USD","IE0009355771.USD","LU0320765489.SGD","LU1057294990.SGD","LU0648001328.SGD","LU0965509010.AUD","LU2360032135.SGD","LU0965509101.SGD","LU0130517989.USD","LU1066051225.USD","GNOM","LU2468319806.SGD","LU1929549753.HKD","LU1037948541.HKD","LU0098860793.USD","LU1291159041.SGD","LU0861579265.USD","LU1974910355.USD","LU0130102774.USD","LU0868494617.USD","LU1941712264.USD","LU0265550359.USD","LU0058720904.USD","LU0320765646.SGD","IE00BJT1NW94.SGD","LU1989772923.USD","LU1923622614.USD","GDOC","LU2357627491.SGD","LU2361044865.SGD","LU1093756325.SGD","BK4534","LU2324357040.USD","LU1069347547.HKD","HRTS","SG9999014559.SGD","LU0965509283.SGD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU2106854487.HKD","SG9999014542.SGD","LU0208291251.USD","LU2112291526.USD","BK4550","LU0234572021.USD","LU1934455863.HKD","LU1023059063.AUD","BK4516","LU2023250504.SGD","SG9999002232.USD","LU0859254822.USD","LU1917777945.USD","PPH","BK4139","TRUH","LU2125154778.USD","XLV","LU2491050154.USD","LU0122379950.USD","MRNX","LU2491049909.HKD","LU2089984988.USD","LU1571399168.USD","BK4533","SG9999014567.USD","LU1162221912.USD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU0965508806.USD","LU0106261372.USD","SG9999015358.SGD","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662693000","title":"焦點-超越體重：男性紛紛前往美容診所，以實現減肥蜕變","url":"https://stock-news.laohu8.com/highlight/detail?id=2662693000","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662693000?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:01","pubTimestamp":1787911288,"startTime":"0","endTime":"0","summary":"焦点-超越体重：男性纷纷前往美容诊所，以实现减肥蜕变外科医生指出，社交媒体和不断变化的男性气概规范是男性美容需求日益增长的原因GoodRx数据显示，男性目前占减肥药使用者的28.3%医生预计，随着包括口服药在内的新型减肥药问世，需求将进一步增长Sriparna Roy路透8月28日-患者和整形外科医生表示，随着畅销减肥药帮助更多美国男性瘦身，越来越多的人正在寻求针对皮肤松弛、脱发和牙齿问题的美容治疗，以完成他们的身体蜕变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4T44P0PP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU2168564149.EUR","LU2471134879.HKD","LU0210536198.USD","LU2023250504.SGD","SG9999013999.USD","IE00BKPKM429.USD","LU1366192091.USD","LU0456855351.SGD","LU2168564495.EUR","SGXZ51526630.SGD","LU0471298777.SGD","THNR","LU1267930730.SGD","LU1548497426.USD","LU0964807845.USD","LU1868837300.USD","LU0943347566.SGD","SG9999015978.USD","BK4007","IE00BJLML261.HKD","LU0432979614.USD","SG9999014906.USD","LU0234572021.USD","NVOX","LU0158827948.USD","OZEM","LU0289739699.SGD","LU0079474960.USD","LU1720051017.SGD","IE00BN29S564.USD","LU2461242641.AUD","LLII","BK4599","SGXZ31699556.SGD","TMED","LU2471134796.USD","LU0158827781.USD","LU0672654240.SGD","IYH","SG9999018865.SGD","LU0345770993.USD","LU2357305700.SGD","LU2552382132.HKD","LU0106261372.USD","BK4532","LU2089283258.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","CURE","ELIS","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0640476718.USD","LU1232071149.USD","LU1280957306.USD","LU2491049909.HKD","LU2456880835.USD","MHIP","SG9999015952.SGD","LU0385154629.USD","BK4516","LU1064131342.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","LU0256863811.USD","LU0256863902.USD","IE0004445239.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","LU0823434583.USD","LU0203202063.USD","LU0122379950.USD","LU1057294990.SGD","LU0787776722.HKD","LU2417539215.USD","IE00B1XK9C88.USD","LU2746668974.SGD","LU2462157665.USD","FHLC","ELIL","LU1023059063.AUD","LU2552382058.USD","LU2750360641.GBP","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0354030511.USD","LU2236285917.USD","LU0345770308.USD","LU0006306889.USD","LU0316494557.USD","LU2211815571.USD","PJP","LU0820561818.USD","IE00BJJMRX11.SGD","LU2213496289.HKD","LU2471134523.USD","SG9999001176.SGD","LU2746668461.USD","BK4533","LU1868836591.USD","SG9999017495.SGD","MEDX","LU1551013342.USD","LU0823434740.USD","SG9999014880.SGD","SGXZ81514606.USD","GB00BDT5M118.USD","LU2552382215.SGD","LU0683600562.USD","LU0109394709.USD","LU0820561909.HKD","LU1127390331.HKD","LU1551013425.SGD","LU0266013472.USD","AGNG","LU2168564065.EUR","LU0174119429.USD","LU0238689110.USD","LU2237443895.HKD","LU2360106947.USD","LU1868836757.USD","LU0353189680.USD","LU1814569148.SGD","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","LU0882574139.USD","IE0004445015.USD","LU1979441026.SGD","IXJ","LU2462591350.SGD","NVOC","LU0154236417.USD","SGXZ57979304.SGD","HRTS","LU1868836914.USD","CANC","LU1093756325.SGD","IE00B7KXQ091.USD","MEDI","LU1061106388.HKD","RXL","SG9999014914.USD","LU1712237335.SGD","VHT","LU2023251221.USD","LU2089984988.USD","LU2168563687.JPY","IE00B775H168.HKD","LU2089284900.SGD","LU0109391861.USD","LU2237443549.SGD","LU0882574055.USD","LLYX","IHE","LU0094547139.USD","LU0198837287.USD","LU0823416689.USD","LU0097036916.USD","LU2168564222.USD","LU1988902786.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","SG9999018857.SGD","IE0002141913.USD","IE00BK4W5L77.USD","LU0096364046.USD","LU1974910355.USD","LU0133085943.USD","LU2271345857.HKD","IE00BKVL7J92.USD","LU0225283273.USD","LU2237438978.USD","SG9999014898.SGD","LU1323610961.USD","LU0320765059.SGD","WDNA","SG9999015945.SGD","LLYZ","LU0471298694.HKD","IE0001KFT4U8.USD","BK4588","IE0005OL40V9.USD","PPH","LU2361044949.HKD","LU2491050071.SGD","LU1868837136.USD","LU2264538146.SGD","LLY","IE00BJJMRY28.SGD","LU1720051108.HKD","BK4581","LU0353189763.USD","LU2237443465.HKD","FTXH","LU2237443978.SGD","XLV","LU0689472784.USD","LU1804176565.USD","LU2265009873.SGD","LU2750360997.AUD","IE00BFSS8Q28.SGD","JDOC","LU2112291526.USD","LU0354030438.USD","IE00B4JS1V06.HKD","LU0323591593.USD","LU1629891620.HKD","LU2471134952.CNY","NVOH","LU0061475181.USD","LU0466842654.USD","IE00BK4W5M84.HKD","LU1989771016.USD","LU1069344957.HKD","LU1145028129.USD","LU1093756168.USD","LU2106854487.HKD","IE0009355771.USD","LU0417517546.SGD","LU2468319806.SGD","TRUH","LU1983299246.USD","NVO","LU2023250330.USD","LU0114720955.EUR","LU0786609619.USD","LU2237443622.USD","LU2111349929.HKD","LU0820562030.AUD","LU2063271972.USD","LU1691799644.USD","LU1035775433.USD","LU2896262040.SGD","LU1623119135.USD","LU0708995401.HKD","LU2361045086.USD","IE00BWXC8680.SGD","LU2756315318.SGD","LU2087625088.SGD","LU2602419157.SGD","SG9999015986.USD","GDOC","ILDR","LU2237443382.USD","LU0889565916.HKD","LU2108987350.USD","LU2361044865.SGD","LU2491050154.USD","SG9999001176.USD","LU1917777945.USD","BK4534","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662057892","title":"金佰利·克拉克尋求歐盟批准這筆400億美元的Kenvue收購交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057892","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662057892?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 15:49","pubTimestamp":1787903373,"startTime":"0","endTime":"0","summary":"金佰利·克拉克寻求欧盟批准这笔400亿美元的Kenvue收购交易路透8月28日-欧盟委员会网站上的文件显示，金佰利·克拉克KMB.O已向欧盟监管机构申请批准其拟以400亿美元 (link) 收购泰诺（Tylenol）制造商肯维（Kenvue）的交易。金佰利·克拉克于去年11月宣布了此次收购计划。该公司当时表示，该交易预计将于2026年下半年完成。金佰利·克拉克预计该交易将带来21亿美元的年度成本节约。该公司表示，通过收购肯维旗下从李施德林漱口水到艾维诺、露得清等护肤品牌的庞大产品组合，合并后公司预计将实现约320亿美元的年收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4S44P0IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IE00BDGV0183.EUR","LU0289739699.SGD","LU0882574055.USD","LU0640476718.USD","RSPS","KVUE","LU0058720904.USD","BMED","LU1585245621.USD","SG9999002232.USD","LU2347655156.SGD","LU1506573853.SGD","IHE","LU1280957306.USD","LU2129689431.USD","LU1061106388.HKD","LU0114720955.EUR","LU2430703095.HKD","LU2471134952.CNY","GLAM","JDOC","LU2456880835.USD","VHT","BK4568","LU1023059063.AUD","LU1732799900.SGD","LU2602419157.SGD","JNJ","LU2417539215.USD","LU0683600562.USD","IXJ","TRUH","FHLC","RXL","MEDX","GDOC","BK4585","LU0545562505.USD","IE00B42XCP33.USD","IYH","LU1043141123.HKD","XLV","LU2213496289.HKD","LU1244550494.USD","LU0795875086.SGD","BK4588","LU0320765646.SGD","KMB","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639772","title":"伯維（ABBV）向EMA遞交Skyrizi克羅恩病治療上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639772","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639772?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:56","pubTimestamp":1787821007,"startTime":"0","endTime":"0","summary":"Skyrizi此前已经在银屑病、银屑病关节炎等多个自身免疫疾病领域拿到欧洲地区的获批资质，如若本次克罗恩病适应症顺利获批，将进一步拓宽该产品在欧洲炎症性肠病赛道的市场空间。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDBhOTg3YTMxNzM2MjM3OTI3ODI2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","IYH","LU0058720904.USD","LU0128525929.USD","LU2023251221.USD","IXJ","LU2087621335.USD","LU1236620834.HKD","LU2125909593.SGD","MEDX","PPH","EMA","LU0289739699.SGD","IE0004445239.USD","LU0234572021.USD","AGNG","PJP","JDOC","LU0965508806.USD","FTXH","LU0882574055.USD","SG9999011175.SGD","VHT","LU0114720955.EUR","BK4533","BK4559","LU1989771016.USD","LU2133065610.SGD","LU0472753341.HKD","LU0985320562.USD","LU0661504455.SGD","LU1236620750.USD","LU2089283258.USD","LU1732799900.SGD","LU0417517546.SGD","LU2237443622.USD","IE000F7OJYX1.SGD","LU2125909247.SGD","FHLC","LU1839511570.USD","SG9999001440.SGD","IE00BLSP4239.USD","ABBV","TRUH","XLV","GLAM","LU0198837287.USD","RXL","LU1585245621.USD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774757","title":"中國批准強生公司口服銀屑病藥，該藥企表示","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774757","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774757?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:54","pubTimestamp":1787820888,"startTime":"0","endTime":"0","summary":"中国批准强生公司口服银屑病药，该药企表示路透上海8月27日-强生公司（JNJ.N）周四表示，其口服药物伊科特罗金拉（icotrokinra）已在中国获批用于治疗中重度斑块型银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O0R7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","FTXH","FHLC","LU2456880835.USD","SG9999013999.USD","LU0124676726.USD","TRUH","JNJ","LU0345770308.USD","LU0882574055.USD","LU2487616109.SGD","JDOC","IYH","IE00BZ1G4Q59.USD","BK4588","VHT","LU2471134796.USD","LU1228905540.USD","RXL","IE00B2B36J28.USD","LU1221951046.USD","GDOC","LU2471134952.CNY","LU0640476718.USD","LU2602419157.SGD","SG9999001440.SGD","LU2430703178.SGD","MEDX","IXJ","LU0545562505.USD","IE00BGHQF631.EUR","SG9999001176.SGD","LU0345770993.USD","LU0053666078.USD","LU0162691827.USD","LU0345769631.USD","LU1983299246.USD","LU2023250330.USD","LU2089984988.USD","LU1244550494.USD","LU1074936037.SGD","LU0210536198.USD","LU1291159041.SGD","LU2236285917.USD","LU1032955483.USD","LU2896262040.SGD","PJP","LU1506573853.SGD","XLV","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113704178","title":"強生口服Icotrokinra在華獲批，用於治療中重度斑塊狀銀屑病","url":"https://stock-news.laohu8.com/highlight/detail?id=1113704178","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113704178?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:49","pubTimestamp":1787820549,"startTime":"0","endTime":"0","summary":"强生公司宣布，其口服药物Icotrokinra已获得中国监管部门的批准，用于治疗中重度斑块状银屑病。这一消息通过官方声明对外发布。\n该药物为患者提供了一种新的治疗选择，尤其针对那些患有中度至重度斑块状银屑病的成人群体。此次获批标志着强生在中国皮肤病治疗领域迈出了重要一步。\n值得注意的是，Icotrokinra作为一种口服疗法，相较于传统的注射或外用药物，可能为患者带来更多便利性和依从性。强生方面表示，将继续致力于为全球患者提供创新的医疗解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU2417539215.USD","IXJ","LU2129689431.USD","LU0466842654.USD","LU1585245621.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU1732800096.USD","XLV","LU0098860793.USD","LU0912757837.SGD","LU0345769128.USD","LU1059921491.USD","VHT","LU1043141396.HKD","BK4532","LU1989771016.USD","LU1074936037.SGD","LU2468319806.SGD","IHE","LU1778281490.HKD","LU0889566641.SGD","SG9999001176.USD","JNJ","LU1732799900.SGD","BK4534","LU1551013425.SGD","LU0122379950.USD","BK4533","IE00BBT3K403.USD","IE00BKVL7J92.USD","LU1267930813.SGD","LU0792757196.USD","LU1244550494.USD","LU1061106388.HKD","LU0070217475.USD","LU0689472784.USD","LU1244550577.SGD","LU0820561818.USD","LU2236285917.USD","IE00B4R5TH58.HKD","IYH","LU0640476718.USD","LU1057294990.SGD","LU2471134952.CNY","BK4588","FTXH","IE00B2B36J28.USD","IE00BVYPNV92.GBP","IE00B7SZLL34.SGD","BK4568","LU0203347892.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU0683600562.USD","IE000MB6IJN5.SGD","LU1496350502.SGD","SGXZ57979304.SGD","LU2756315318.SGD","LU0795875086.SGD","LU0345769631.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2592432038.USD","LU0320765646.SGD","LU1121112475.USD","LU1674673691.USD","LU0114720955.EUR","LU0994945656.USD","LU0053666078.USD","IE00B3T34201.USD","LU1221951046.USD","IE00BN8TJ469.HKD","LU2456880835.USD","LU2471134879.HKD","LU1506573853.SGD","LU1551013342.USD","FHLC","BK4559","LU2756315664.SGD","LU1629891620.HKD","LU1023059063.AUD","IE0001KFT4U8.USD","LU0234570918.USD","BK4504","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1066051225.USD","IE00BLSP4452.SGD","LU2129689514.USD","LU0426412945.USD","LU0689626769.HKD","LU1983299246.USD","IE0002270589.USD","LU1935042991.SGD","LU1261432733.SGD","LU2347655156.SGD","LU1032466523.USD","LU2430703251.USD","LU0943347566.SGD","LU2112291526.USD","GDOC","LU2129689605.HKD","LU0162691827.USD","LU0426417589.USD","LU1894683348.USD","JDOC","IE00BGHQF631.EUR","SGXZ80539844.SGD","IE0000B7K699.USD","LU0787776722.HKD","LU2487616109.SGD","PJP","LU2403377893.USD","BK4581","LU0820561909.HKD","LU0820562030.AUD","LU1196500208.SGD","IE0002141913.USD","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU0072461881.USD","LU1280957306.USD","LU0210536198.USD","LU1244550221.USD","LU0882574055.USD","LU0545562505.USD","LU1929549753.HKD","BK4007","TRUH","BK4550","LU1228905540.USD","LU0964807845.USD","LU1718418525.SGD","LU1894683264.USD","IE000SO60NU8.SGD","LU0058720904.USD","LU0985320562.USD","LU0210528500.USD","LU1228905037.USD","BK4585","SG9999001440.SGD","LU1162221912.USD","LU1914381329.SGD","LU0289739699.SGD","LU1066051498.USD","LU1145028129.USD","IE000WAW04H5.SGD","IE0034235303.USD","LU0234572021.USD","SG9999013999.USD","IE00BZ1G4Q59.USD","LU1221951129.SGD","LU0432979614.USD","LU2750360997.AUD","LU2213496289.HKD","MEDX","IE000F7OJYX1.SGD","LU0203345920.USD","LU2505996681.GBP","LU2471134523.USD","LU1043141123.HKD","LU1291159041.SGD","LU2023250330.USD","IE00B1BXHZ80.USD","IE00BFXG1179.USD","IE00B3PB1722.GBP","RXL","BMED","LU2750360641.GBP","IE00B42XCP33.USD","IE0009355771.USD","LU0124676726.USD","SG9999002224.SGD","LU2896262040.SGD","LU2430703178.SGD","LU1032955483.USD","LU0795875169.SGD","IE00BLSP4239.USD","LU0345770308.USD","LU2089984988.USD","LU0345770993.USD","LU2471134796.USD","LU2430703095.HKD","LU2133065610.SGD","LU1430594728.SGD","LU2602419157.SGD","SG9999002232.USD","BK4592","LU1066053197.SGD","IE00BVYPNW00.USD","SG9999001176.SGD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774566","title":"強生公司8月27日宣佈，白介素23（IL-23）受體拮抗劑艾特雅（鹽酸伊可白滯素片）已正式獲得中國國家藥品監督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774566?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:40","pubTimestamp":1787820043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0001KFT4U8.USD","LU1244550494.USD","SGXZ80539844.SGD","FTXH","RXL","IXJ","SG9999001176.SGD","LU1228905540.USD","JNJ","IE00BSNM7G36.USD","LU2471134523.USD","LU1074936037.SGD","IHE","SG9999013999.USD","BK4532","LU1989771016.USD","LU2417539215.USD","LU2468319806.SGD","LU2505996509.AUD","MEDX","TRUH","LU0289739699.SGD","IE00B4R5TH58.HKD","FHLC","LU0964807845.USD","LU2403377893.USD","JDOC","PJP","GDOC","BK4007","LU0820562030.AUD","IE00BFXG1179.USD","LU1228905037.USD","VHT","LU1261432733.SGD","LU1551013342.USD","LU0882574055.USD","IE0002270589.USD","BK4534","LU2112291526.USD","BMED","LU0985320562.USD","XLV","LU1221951129.SGD","IE00B3T34201.USD","IYH","LU0912757837.SGD","LU2896262040.SGD","LU0683600562.USD","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662777108","title":"強生靶向口服肽類藥物艾特雅在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2662777108","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662777108?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:33","pubTimestamp":1787819601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JNJ","LU2750360997.AUD","LU0889566641.SGD","LU0994945656.USD","LU2403377893.USD","LU2430703095.HKD","RXL","VHT","LU2487616109.SGD","LU0689472784.USD","LU2430703178.SGD","LU1244550494.USD","PJP","FHLC","GDOC","LU0114720955.EUR","LU1043141396.HKD","LU2023250330.USD","LU0683600562.USD","LU1629891620.HKD","IE00BVYPNW00.USD","LU0070217475.USD","LU1023059063.AUD","LU1718418525.SGD","LU2129689514.USD","MEDX","BK4568","XLV","LU1221951046.USD","IE00BSNM7G36.USD","LU2756315664.SGD","BK4007","IE000M9KFDE8.USD","FTXH","IE00B1BXHZ80.USD","IXJ","LU0466842654.USD","IE000SO60NU8.SGD","LU2471134796.USD","IYH","LU1059921491.USD","BMED","BK4533","LU1430594728.SGD","IHE","LU2133065610.SGD","TRUH","IE000WAW04H5.SGD","JDOC","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677565","title":"兩大減肥藥巨頭競逐中國市場：口服減重版司美格魯肽國內上市申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677565","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677565?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:41","pubTimestamp":1787812915,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RXL","FHLC","IYH","IE00BJJMRY28.SGD","LLII","LU0266013472.USD","BK4534","LU1280957306.USD","LU1093756325.SGD","LU0889565916.HKD","BK4533","IE00BFSS8Q28.SGD","LU0683600562.USD","LU2106854487.HKD","LU2023250504.SGD","LLY","LU2264538146.SGD","SG9999014914.USD","SGXZ57979304.SGD","LU0820561818.USD","LU2471134952.CNY","NVO","LU2746668461.USD","TMED","LU2063271972.USD","LU0708995401.HKD","IXJ","LU1712237335.SGD","LU2237438978.USD","LU2237443382.USD","LU2237443978.SGD","SG9999001176.SGD","LU2471134879.HKD","LU2213496289.HKD","LU2360106947.USD","IE00B4JS1V06.HKD","LU0820561909.HKD","LU0823434583.USD","SG9999015986.USD","XLV","LU1323610961.USD","LU2089984988.USD","IE00BK4W5L77.USD","MHIP","IE00BZ1G4Q59.USD","LU0323591593.USD","LU1551013425.SGD","LU2168564495.EUR","LU2491050071.SGD","LU2471134796.USD","IE0002141913.USD","LU0097036916.USD","LU0106261372.USD","LU0320765059.SGD","LU0689472784.USD","LU0882574055.USD","LU1868836914.USD","LU0210536198.USD","SG9999013999.USD","GB00BDT5M118.USD","LU2271345857.HKD","CURE","CANC","PPH","LU0198837287.USD","LU2089283258.USD","SG9999018865.SGD","LU0882574139.USD","HRTS","LU2746668974.SGD","LU0061475181.USD","LU0385154629.USD","LU1057294990.SGD","SGXZ99366536.SGD","LU2023250330.USD","LU0432979614.USD","LU0114720955.EUR","IE00B2B36J28.USD","LU2108987350.USD","LU1691799644.USD","IE00BFSS7M15.SGD","LU2237443622.USD","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2111349929.HKD","LU0203201768.USD","LU0640476718.USD","LU1291159041.SGD","IE00BKDWB100.SGD","LU2112291526.USD","LU0109391861.USD","LU1974910355.USD","LU2361044865.SGD","LU2756315318.SGD","BK4516","IE00BKPKM429.USD","AGNG","LU0456855351.SGD","LU1069344957.HKD","GDOC","LU0256863811.USD","LU2456880835.USD","LU2461242641.AUD","LU2471134523.USD","LU0672654240.SGD","LU2462591350.SGD","IE00BJT1NW94.SGD","BK4581","LU0820562030.AUD","LU2357305700.SGD","LU2468319806.SGD","LU2491050154.USD","LU0471298777.SGD","SG9999015952.SGD","LU0964807845.USD","IE0001KFT4U8.USD","LU1989771016.USD","IE0004445239.USD","LU2756315664.SGD","LU0109394709.USD","LU0345770308.USD","LU2265009873.SGD","SG9999014880.SGD","LU2237443465.HKD","WDNA","IE0009355771.USD","LU1023059063.AUD","LU2168564222.USD","LU0006306889.USD","LU1127390331.HKD","LU2211815571.USD","SG9999001176.USD","FTXH","IE00BWXC8680.SGD","JDOC","LU2361044949.HKD","SG9999017495.SGD","BK4599","LU0466842654.USD","LU0154236417.USD","LU0225283273.USD","LU2552382215.SGD","IE00BJLML261.HKD","SG9999018857.SGD","LU2602419157.SGD","LU0289739699.SGD","MEDI","SG9999014898.SGD","LU2023251221.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","LU2168563687.JPY","LU0345770993.USD","LU0471298694.HKD","LU2089284900.SGD","IE00B1XK9C88.USD","LU1267930730.SGD","BK4532","LU1868837300.USD","LU2237443895.HKD","LU1366192091.USD","NVOX","LU0256863902.USD","LU0786609619.USD","IE00B7KXQ091.USD","LU1868836757.USD","SG9999015978.USD","LU1868836591.USD","LU1720051108.HKD","LU1979441026.SGD","MEDX","IE00B775H168.HKD","ELIS","LU1868837136.USD","LU2417539215.USD","LU0943347566.SGD","LU0122379950.USD","ELIL","LU0823434740.USD","LU1145028129.USD","LU2168564149.EUR","LU0354030511.USD","LU0094547139.USD","LU1983299246.USD","LU2236285917.USD","LU2324357040.USD","IHE","LU1061106388.HKD","LU2361045086.USD","LU2491049909.HKD","ILDR","LLYZ","LU0320765992.SGD","LU0158827781.USD","IE00BN29S564.USD","LU2087625088.SGD","LU2168564065.EUR","LU0787776722.HKD","BK4588","BK4007","LU0174119429.USD","LU0316494557.USD","LU0133085943.USD","LU0353189763.USD","LU0353189680.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0234572021.USD","NVOH","LU1804176565.USD","LU2237443549.SGD","LU2552382132.HKD","LU1035775433.USD","IE0004445015.USD","LU0823416689.USD","LU1917777945.USD","IE00BKVL7J92.USD","SG9999014906.USD","LU2462157665.USD","NVOC","TRUH","LU2750360641.GBP","LU2750360997.AUD","LU1093756168.USD","SGXZ51526630.SGD","LU1548497426.USD","THNR","IE00B1BXHZ80.USD","IE0005OL40V9.USD","LU0203202063.USD","LU1814569148.SGD","IE00BFTCPJ56.SGD","LU0158827948.USD","IE00B4R5TH58.HKD","LLYX","LU1064131342.USD","LU1629891620.HKD","PJP","LU0354030438.USD","LU0417517546.SGD","LU1232071149.USD","LU1988902786.USD","LU1551013342.USD","LU2028103732.USD","LU2552382058.USD","VHT","LU1623119135.USD","SGXZ81514606.USD","LU0079474960.USD","SG9999015945.SGD","LU0238689110.USD","LU0096364046.USD","BK4585","OZEM","LU2896262040.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195775229","title":"艾伯維向歐洲藥品管理局提交Skyrizi®（瑞莎珠單抗）皮下誘導治療申請，針對中重度活動性克羅恩病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1195775229","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195775229?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810433,"startTime":"0","endTime":"0","summary":"艾伯维公司已正式向欧洲药品管理局递交了一项监管申请，旨在寻求Skyrizi皮下注射剂型的上市许可。该申请针对的适应症为——用于治疗患有中重度活动性克罗恩病的成年患者，且此方案将作为诱导治疗手段。若此次申请获得批准，Skyrizi的皮下给药方式将为患者提供更为便捷的治疗选择，有望改善治疗依从性与患者体验。此次针对克罗恩病皮下诱导治疗的申请，进一步丰富了Skyrizi的潜在临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0211328371.USD","LU0820561818.USD","BK4533","LU1236620750.USD","LU0985320562.USD","LU1267930490.SGD","LU0098860793.USD","IE00BGHQF631.EUR","LU2433249047.HKD","LU1670628061.USD","LU0456855351.SGD","LU2237443465.HKD","SG9999015978.USD","LU1732800096.USD","LU1244550494.USD","LU0289961442.SGD","LU1244550221.USD","LU1934455863.HKD","LU2125909247.SGD","LU1093756325.SGD","LU1585245621.USD","LU0289739343.SGD","LU2129689514.USD","LU1496350502.SGD","LU2112291526.USD","LU2237443382.USD","PJP","LU0661504455.SGD","LU1496350171.SGD","LU0170899867.USD","IE00B19Z3581.USD","LU0057025933.USD","IE00BVYPNV92.GBP","LU0114720955.EUR","LU0417517546.SGD","LU2089283258.USD","LU1267930573.SGD","LU1670627923.USD","LU0795875169.SGD","LU2087621335.USD","SG9999011175.SGD","LU1057294990.SGD","IE00BSNM7G36.USD","LU2237443978.SGD","LU1074936037.SGD","IE00BVYPNW00.USD","LU0203345920.USD","LU1718418525.SGD","IE00BJT1NW94.SGD","LU0689626769.HKD","LU0738911758.USD","LU0545039389.USD","LU1923622614.USD","LU0310800379.SGD","IE00BLSP4452.SGD","IE00B3PB1722.GBP","LU0058720904.USD","LU1037948897.HKD","LU1989772923.USD","BK4559","RXL","LU1093756168.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU0432979614.USD","IXJ","IE000SO60NU8.SGD","LU1839511570.USD","LU2089984988.USD","LU2237443895.HKD","SG9999015986.USD","LU0861579265.USD","PPH","LU0949170772.SGD","IE000BZT7R73.USD","LU1430594728.SGD","LU0795875086.SGD","LU2089284900.SGD","GLAM","LU2347655156.SGD","LU0320765646.SGD","LU0029864427.USD","LU0868494617.USD","LU0868494708.USD","IE000MB6IJN5.SGD","LU0211327993.USD","LU2237443622.USD","BK4139","LU2129689431.USD","AGNG","LU2357627491.SGD","LU0942090050.USD","LU1236620834.HKD","LU0726765562.USD","IE000F7OJYX1.SGD","LU1037948541.HKD","LU0689472784.USD","LU2347655073.USD","IE0004445239.USD","IE00B4R5TH58.HKD","LU1732799900.SGD","LU0069063385.USD","LU0203347892.USD","LU0820561909.HKD","SG9999015945.SGD","LU0882574055.USD","LU1003077747.HKD","SG9999015952.SGD","IE00BBT3K403.USD","LU1551013342.USD","IE0000B7K699.USD","VHT","IE0002270589.USD","LU1023059063.AUD","LU0256863902.USD","MEDX","LU2133065610.SGD","LU0965508806.USD","LU1551013425.SGD","IE00B42XCP33.USD","LU0708994859.HKD","LU0859254822.USD","LU0965509283.SGD","LU1983299246.USD","BK4588","IE00BN8TJ469.HKD","LU0472753341.HKD","LU1934455277.USD","TRUH","LU1989771016.USD","LU0124676726.USD","LU1934455194.USD","LU1291159041.SGD","LU2023251221.USD","LU0310799852.SGD","BK4550","JDOC","LU0234570918.USD","LU0511384066.AUD","IE00B19Z3B42.SGD","LU0965509010.AUD","XLV","LU1989772840.SGD","LU0965509101.SGD","LU0128525929.USD","LU0234572021.USD","LU2237443549.SGD","LU0553294199.USD","LU2125909593.SGD","IE00BDGV0183.EUR","LU0198837287.USD","LU1162221912.USD","BK4581","ABBV","IE00B2B36J28.USD","LU0158827948.USD","LU0823416689.USD","IE0009355771.USD","LU0256863811.USD","LU2129689605.HKD","IE00BFTCPJ56.SGD","LU1929549753.HKD","IYH","LU0395794307.EUR","LU0122379950.USD","BK4585","LU2468319806.SGD","LU0912757837.SGD","FTXH","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","SG9999001440.SGD","LU1244550577.SGD","IE000WAW04H5.SGD","BK4534","SG9999003800.SGD","BK4566","FHLC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}